Literature DB >> 31896273

An Examination of Comorbid Generalized Anxiety Disorder and Chronic Pain on Substance Misuse in a Canadian Population-Based Survey.

Elena Bilevicius1,2, Jordana L Sommer1,2, Matthew T Keough3, Renée El-Gabalawy1,2,4,5.   

Abstract

OBJECTIVES: Chronic pain and generalized anxiety disorder (GAD) are co-occurring, and both conditions are independently associated with substance misuse. However, limited research has examined the impact of comorbid GAD and chronic pain on substance misuse. The aim of this article was to examine the associations between comorbid GAD and chronic pain conditions compared to GAD only with nonmedical opioid use, drug abuse/dependence, and alcohol abuse/dependence in a Canadian, population-based sample.
METHODS: Data came from the 2012 Canadian Community Health Survey-Mental Health (N = 25,113). Multiple logistic regressions assessed the associations between comorbid GAD and chronic pain conditions (migraine, back pain, and arthritis) on substance misuse.
RESULTS: Comorbid GAD + back pain and GAD + migraine were associated with increased odds of nonmedical opioid use compared to GAD only. However, the relationship was no longer significant after controlling for additional chronic pain conditions. No significant relationship was found between GAD + chronic pain conditions with drug or alcohol abuse/dependence.
CONCLUSIONS: Comorbid GAD + back pain and GAD + migraine have a unique association with nonmedical opioid use in Canadians compared to GAD only, and chronic pain multimorbidity may be driving this relationship. Results emphasize the need for screening for substance misuse and prescription access in the context of GAD and comorbid chronic pain.

Entities:  

Keywords:  chronic pain; comorbidity; generalized anxiety disorder; nonmedical opioid

Year:  2020        PMID: 31896273      PMCID: PMC7265603          DOI: 10.1177/0706743719895340

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  48 in total

1.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

2.  Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Risë B Goldstein; S Patricia Chou; Sharon M Smith; Jeesun Jung; Haitao Zhang; Tulshi D Saha; Roger P Pickering; W June Ruan; Boji Huang; Bridget F Grant
Journal:  J Stud Alcohol Drugs       Date:  2015-05       Impact factor: 2.582

3.  Managing patients with mental and physical multimorbidity.

Authors:  Stewart W Mercer; Jane Gunn; Peter Bower; Sally Wyke; Bruce Guthrie
Journal:  BMJ       Date:  2012-09-03

4.  Comorbidity of fibromyalgia and psychiatric disorders.

Authors:  Lesley M Arnold; James I Hudson; Paul E Keck; Megan B Auchenbach; Kristin N Javaras; Evelyn V Hess
Journal:  J Clin Psychiatry       Date:  2006-08       Impact factor: 4.384

5.  Evaluating the use and timing of opioids for the treatment of migraine headaches in the emergency department.

Authors:  Stephen V Tornabene; Reena Deutsch; Daniel P Davis; Theodore C Chan; Gary M Vilke
Journal:  J Emerg Med       Date:  2008-02-14       Impact factor: 1.484

Review 6.  Anxiety disorders and comorbid medical illness.

Authors:  Peter P Roy-Byrne; Karina W Davidson; Ronald C Kessler; Gordon J G Asmundson; Renee D Goodwin; Laura Kubzansky; R Bruce Lydiard; Mary Jane Massie; Wayne Katon; Sally K Laden; Murray B Stein
Journal:  Gen Hosp Psychiatry       Date:  2008 May-Jun       Impact factor: 3.238

Review 7.  Substance use disorders and anxiety: a treatment challenge for social workers.

Authors:  Kathleen T Brady; Louise F Haynes; Karen J Hartwell; Therese K Killeen
Journal:  Soc Work Public Health       Date:  2013

8.  Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample.

Authors:  Lachlan A McWilliams; Brian J Cox; Murray W Enns
Journal:  Pain       Date:  2003-11       Impact factor: 6.961

Review 9.  CDC Guideline for Prescribing Opioids for Chronic Pain--United States, 2016.

Authors:  Deborah Dowell; Tamara M Haegerich; Roger Chou
Journal:  JAMA       Date:  2016-04-19       Impact factor: 56.272

10.  Characteristics of opioid-users whose death was related to opioid-toxicity: a population-based study in Ontario, Canada.

Authors:  Parvaz Madadi; Doris Hildebrandt; Albert E Lauwers; Gideon Koren
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more
  1 in total

1.  Public awareness and anxiety during COVID-19 epidemic in China: A cross-sectional study.

Authors:  Yunyu Liu; Pengfei Li; Yalan Lv; Xiaorong Hou; Qingmao Rao; Juntao Tan; Jun Gong; Chao Tan; Lifan Liao; Weilu Cui
Journal:  Compr Psychiatry       Date:  2021-03-11       Impact factor: 3.735

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.